Vincent Gallet

Novartis receives traditional approval in IgAN

Novartis says the US FDA has granted traditional approval to Fabhalta (iptacopan) to slow the decline in kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of disease progression.

July 17, 2026 at 09:50 am

DBV Technologies widens its net loss in the first half

DBV Technologies reported a net loss of $98m for the six months ended June 30, 2026, versus $69m a year earlier. On a per-share basis, however, it narrowed to $0.23 from $0.58, thanks to a significant strengthening of its equity base following recent financings.

July 17, 2026 at 09:32 am

Uber rises after its acquisition of Delivery Hero and Wedbush comments

Uber Technologies gained 1.9% to a little over $74 on Thursday on Wall Street, after the group announced an agreement to acquire Delivery Hero, and with support from Wedbush commentary that names it as one of its favorite Internet stocks.

July 17, 2026 at 09:07 am

Uber lifted by its takeover of Delivery Hero and Wedbush comments

Uber Technologies is up 2.5% at $74.5 in early Wall Street trading, after the group announced an agreement to acquire Delivery Hero, and with support from comments by Wedbush, which names it as one of its favorite stocks in the internet sector.

July 16, 2026 at 07:02 pm

Uber lifted by its acquisition of Delivery Hero and Wedbush comments

Uber Technologies is up 2.5% at $74.5 in early trading on Wall Street, after the group announced an agreement to acquire Delivery Hero, and with support from comments by Wedbush, which ranks it among its favorite Internet sector picks.

July 16, 2026 at 07:00 pm

Brussels takes two sets of measures against Google

The European Commission is announcing two sets of binding specification measures aimed at Google, to 'enable companies to offer European users a broader and more feature-rich range of options, both for their AI services on Android and for search services'.

July 16, 2026 at 05:39 pm

Abbott raises its 2026 adjusted EPS target range

As it reports its second-quarter results, Abbott Laboratories says it is raising its target range for adjusted EPS for full-year 2026, now set at between $5.45 and $5.60, versus a previous range of $5.38 to $5.58.

July 16, 2026 at 04:06 pm

Schaeffler higher on broker upgrade

Schaeffler is up 2.1% at €8.55 in Frankfurt, in the wake of an upgrade by UBS on the auto parts maker's shares, following a preliminary presentation of its Q2 2026 results on Tuesday evening.

July 16, 2026 at 02:52 pm

Broker notes give ASML a modest lift

After ending Wednesday's session down 0.4% in Amsterdam, ASML is back up 0.5% at around €1,560 this Thursday morning, helped by a wave of favorable broker recommendations reacting to its quarterly results released the day before.

July 16, 2026 at 12:27 pm

Vinci Energies launches a tender offer for All for One in Germany

Vinci Energies announced the launch of a public tender offer for All for One, a German specialist in the integration and maintenance of business applications, based in Filderstadt, near Stuttgart, and listed on the Frankfurt Stock Exchange.

July 16, 2026 at 10:57 am

United Kingdom: industrial output falls in May

After a 0.2% increase in April and flat growth in March, UK industrial production contracted by 0.5% in May 2026 on a sequential basis, according to the Office for National Statistics (ONS).

July 16, 2026 at 10:34 am

Publicis raises its 2026 growth target

On the release of its first-half results, Publicis Groupe said it is raising its 2026 target for organic growth in net revenue, now aiming for organic growth of between +4.5% and +5% for the full year, versus a previous range of +4% to +5%.

July 16, 2026 at 10:09 am

BlackRock praised for robust results and share buybacks

BlackRock jumps 7.3% to around $1,100 early in the Wall Street session, following a quarterly report that topped expectations on both profitability and revenue, highlighted by assets under management at a record level, strength that is allowing management to raise its share buyback target.

July 15, 2026 at 06:41 pm

BNY Mellon beats expectations in the second quarter

Bank of New York Mellon (BNY Mellon) reports, for the second quarter of 2026, net income attributable to shareholders up 22% to nearly $1.70bn, or $2.45 per share (+27%), comfortably above the $2.22 per share expected on average by analysts.

July 15, 2026 at 03:45 pm

ASML cheered for its solid quarter and upbeat targets

ASML is up 4% to €1,620 this morning in Amsterdam, taking its gain since the start of the year to +75%, as investors welcome the sharp upgrade to the group's targets for the current year, after a solid Q2 2026.

July 15, 2026 at 12:38 pm

Societe Generale remains Deutsche Bank's preferred French bank

As the three major listed French banks prepare to report their 2nd-quarter 2026 results, Deutsche Bank is sticking with its preference for Societe Generale, still rated a buy, versus BNP Paribas and Credit Agricole, both rated a hold.

July 15, 2026 at 11:42 am

Ackermans & van Haaren rises on upbeat comments from KBC Securities

Ackermans & van Haaren (AvH) is up 1.5% at €273 in early trading in Brussels, following a ratings upgrade at KBC Securities to 'buy' from 'accumulate', with the price target raised to €320 from €300 for the conglomerate, which notably owns Delen Private Bank and Bank Van Breda.

July 15, 2026 at 11:17 am

Richemont touts a vigorous start to the fiscal year

Richemont, the Swiss luxury giant that owns, among others, Cartier, Van Cleef & Arpels and Montblanc, posted revenue of €6.33bn for its first fiscal quarter (ended late June), up 20% at constant exchange rates and 17% at actual exchange rates.

July 15, 2026 at 10:27 am

ASML raises its 2026 targets

On the release of its quarterly results, ASML announced higher annual targets, now expecting a gross margin of 54% to 56% on revenue of €43bn to €45bn for 2026, versus target ranges of 51% to 53% and €36bn to €40bn presented three months ago.

July 15, 2026 at 09:50 am

IBM hammered after a profit warning and a rating downgrade

Even with the session dominated by a flood of bank earnings on Wall Street, the spotlight this Tuesday is squarely on IBM: shares in the tech giant are plunging 25% to below $218, wiping out all gains booked since the start of the year, hit by a profit warning compounded by a rating downgrade from HSBC.

July 14, 2026 at 06:34 pm

Bank of America boosts EPS by a third in Q2

Bank of America reports EPS up 34% to $1.21 for Q2 2026, helped in particular by 15% revenue growth to $31.6bn, driven by gains in both net interest income (NII), sales and trading revenue, and asset management and investment banking fees.

July 14, 2026 at 03:32 pm